FinCanna Capital (CSE: CALI) (OTCQB: FNNZF), a royalty company for the U.S. licensed medical cannabis industry, this morning announced the appointment of Robert “Bob” Kamm to the company’s Board of Directors. Kamm has more than 25 years of experience operating and advising businesses, including his current role representing FinCanna on the Board of Directors of its investee company, Cultivation Technologies Inc. Jeff Tindale has resigned from the FinCanna Board of Directors making way for Kamm’s appointment. Tindale will continue to serve on FinCanna’s Board of Advisors. In addition, the company announced that on August 29, 2018, it issued a total of 450,000 incentive stock options to a director and an advisor with an exercise price of $0.30 per share and a term of five years. “We are very pleased to welcome Mr. Kamm to our Board of Directors,” FinCanna Capital president and CEO Andriyko Herchak stated in the news release. “Bob has a wide range of business expertise and skills all of which will serve us well as we begin to accelerate our growth trajectory over this next time period. He has an exceptional history of identifying and building high growth companies and we look forward to him applying his talents to the future success of FinCanna. I would also like to thank Mr. Jeff Tindale for his invaluable service on our Board of Directors since FinCanna’s inception and welcome his continued involvement with FinCanna on our Board of Advisors.”
To view the full press release, visit http://cnw.fm/cIJV7
About FinCanna Capital Corp.
FinCanna provides financing to top-tier companies in the licensed medical cannabis industry in exchange for a royalty on revenues. FinCanna, led by a team of finance and industry experts, is building its diversified portfolio of royalty investments in scalable, best-in-class projects and companies in U.S. legal states, with a focus on California. For additional information visit www.FinCannaCapital.com
More from CannabisNewsBreaks
About HempWire
HempWire (HW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) HempNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, HW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. HW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, HW brings its clients unparalleled visibility, recognition and brand awareness. HW is where news, content and information converge.
For more information please visit https://www.hempwire.com
Please see full terms of use and disclaimers on the HempWire website applicable to all content provided by HW, wherever published or re-published: https://www.hempwire.com/disclaimer/
HempWire (HW)
Denver, Colorado
www.hempwire.com
303.498.7722 Office
Editor@HempWire.net
Golden Triangle Ventures (OTC: GTVH) (“GTV”) has completed a major restructuring of its capital structure and…
InMed Pharmaceuticals (NASDAQ: INM), a pharmaceutical company developing small molecule drug candidates for diseases with…
CannabisNewsWire (CNW), a trusted communications platform within the cannabis sector and a part of InvestorBrandNetwork…
Turning Point Brands (NYSE: TPB), a manufacturer, marketer and distributor of branded consumer products, recently…
WEED Inc. (OTCQB: BUDZ), a global cannabis and hemp bioresearch company based in the U.S.,…
Flora (NASDAQ: FLGC) has closed a registered direct offering to institutional investors for the aggregate…